|
Market Closed -
Other stock markets
|
After market 07:08:03 pm | |||
| 145.7 USD | +0.67% |
|
145.4 | -0.26% |
| 12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
| Apr. 18 | Medical device maker Intuitive beats estimates on strong demand for surgical robots | RE |
Johnson & Johnson (NYSE:JNJ) announces a share repurchase program. Under the program, the company will repurchase up to $5,000 million worth of its common stock. The shares repurchased will be available for general corporate purposes.
The program has no time limit. As of July 22, 2022, the company had approximately 2,629,200,000 shares of common stock outstanding.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.02% | 351B | |
| +27.97% | 672B | |
| +23.86% | 550B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.83% | 211B | |
| -0.87% | 203B | |
| -10.47% | 194B | |
| -11.81% | 144B | |
| -8.80% | 141B |
JOHNSON & JOHNSON 
